These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37209053)
21. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. Dodick DW; Sandrini G; Williams P CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530 [TBL] [Abstract][Full Text] [Related]
22. Comparative aspects of triptans in treating migraine. Adelman JU; Lewit EJ Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316 [TBL] [Abstract][Full Text] [Related]
23. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Ferrari MD; Roon KI; Lipton RB; Goadsby PJ Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541 [TBL] [Abstract][Full Text] [Related]
24. The 5-HT Whealy M; Becker WJ Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644 [TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Chen LC; Ashcroft DM Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569 [TBL] [Abstract][Full Text] [Related]
26. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077 [TBL] [Abstract][Full Text] [Related]
27. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. Xu H; Han W; Wang J; Li M J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624 [TBL] [Abstract][Full Text] [Related]
28. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME Headache; 2004; 44(7):661-8. PubMed ID: 15209687 [TBL] [Abstract][Full Text] [Related]
29. Almotriptan: a review of its use in migraine. Keam SJ; Goa KL; Figgitt DP Drugs; 2002; 62(2):387-414. PubMed ID: 11817980 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine. Zhang L; Hay JW CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898 [TBL] [Abstract][Full Text] [Related]
32. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management. Millson DS; Tepper SJ; Rapoport AM Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525 [TBL] [Abstract][Full Text] [Related]
33. [Sumatriptan-naproxen sodium fix-dose combination for acute migraine treatment, a review]. Tajti J; Csáti A; Szok D Ideggyogy Sz; 2023 Sep; 76(9-10):293-296. PubMed ID: 37782065 [TBL] [Abstract][Full Text] [Related]
34. [Economic evaluation of acute migraine attack treatment with triptans in Spain]. Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947 [TBL] [Abstract][Full Text] [Related]
35. Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis. Yang CP; Liang CS; Chang CM; Yang CC; Shih PH; Yau YC; Tang KT; Wang SJ JAMA Netw Open; 2021 Oct; 4(10):e2128544. PubMed ID: 34633423 [TBL] [Abstract][Full Text] [Related]
36. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198 [TBL] [Abstract][Full Text] [Related]